Black Diamond Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
70.00 |
70.00 |
3.89 |
4.98 |
10.49 |
86.32 |
| Przychód Δ r/r |
0.00% |
0.00% |
-94.44% |
27.90% |
110.61% |
723.08% |
| Przychód (min) |
70.00 |
70.00 |
3.89 |
4.98 |
10.49 |
86.32 |
| Przychód (max) |
70.00 |
70.00 |
3.89 |
4.98 |
10.49 |
86.32 |
| EBITDA (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT (średnia) |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| EBIT % |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| Zysk netto (średni) |
-70.95 |
12.38 |
-50.49 |
-95.01 |
-79.79 |
-44.02 |
| Zysk netto % |
-101.36% |
17.69% |
-1296.91% |
-1908.18% |
-760.86% |
-51.00% |
| EPS (średnia) |
-1.30 |
0.23 |
-0.92 |
-1.07 |
-1.45 |
-0.80 |
| Liczba analityków (Przychody) |
5 |
4 |
5 |
4 |
2 |
3 |
| Liczba analityków (EPS) |
6 |
5 |
3 |
4 |
3 |
2 |
| symbol |
BDTX |
BDTX |
BDTX |
BDTX |
BDTX |
BDTX |